Kelonia Therapeutics has emerged as a significant acquisition target in the biotech sector, thanks to its promising developments in cell therapies aimed
Category: Venture Capital
Eli Lilly’s Strategic $3.25 Billion Acquisition of Kelonia Therapeutics
Biorce Moves to ‘El Dau’: Expanding to 2,000 Square Meters to Welcome 250 Employees by 2026
Mending university and venture capital relations: is it possible to see eye-to-eye?
Navigating the Funding Landscape: IPOs, Private Equity, and Venture Capital
Simplifying Green Bond Issuance: A New Era for Sustainable Financing
The Shift in Biotech Investment: U.S. VCs Target Early-Stage Chinese Innovations
Strategic Moves in Japan’s Biotech and Pharmaceutical Landscape
Evolution in Startup Funding Dynamics: A Symphony Beyond Venture Capital
In the realm of startup funding, a new melody is resonating, captivating founders with a symphony that extends far beyond the traditional notes of venture capital. While the echoes of VC investments still reverberate through Silicon Valley, a paradigm shift is underway, redefining the financing landscape for early-stage entrepreneurs. A recent survey by Mercury in […]
Luxury Vacation Rental Startup Raises $50M in Series B Round
Luxury vacation rental startup Wander has secured $50 million in its Series B funding round. With over 1,000 homes signed in just one year, the company aims to expand its coverage further. Chuckie Reddy, partner at QED Investors, highlighted WanderOS as the driving force behind the company’s rapid growth. WanderOS streamlines the onboarding process for […]









